title: PPAR Regulation of Inflammatory Signaling in CNS Diseases.
abstract: Central nervous system (CNS) is an immune privileged site, nevertheless inflammation associates with many CNS diseases. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors that regulate immune and inflammatory responses. Specific ligands for PPARalpha, gamma, and delta isoforms have proven effective in the animal models of multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, and trauma/stroke, suggesting their use in the treatment of neuroinflammatory diseases. The activation of NF-kappaB and Jak-Stat signaling pathways and secretion of inflammatory cytokines are critical in the pathogenesis of CNS diseases. Interestingly, PPAR agonists mitigate CNS disease by modulating inflammatory signaling network in immune cells. In this manuscript, we review the current knowledge on how PPARs regulate neuroinflammatory signaling networks in CNS diseases.
authors.affiliation: Neuroscience Research Laboratory, Methodist Research Institute, Clarian Health, Indianapolis, IN 46202, USA.
authors.forename: John J
authors.initials: JJ
authors.lastname: Bright
authors.forename: Saravanan
authors.initials: S
authors.lastname: Kanakasabai
authors.forename: Wanida
authors.initials: W
authors.lastname: Chearwae
authors.forename: Sharmistha
authors.initials: S
authors.lastname: Chakraborty